Fractional Flow Reserve (FFR) Market Size is expected to grow at a commendable rate between 2022 and 2028. Since several regions across the globe are witnessing a rise in the percentage of people being diagnosed with cardiovascular ailments, the adoption of the Fractional Flow Reserve (FFR) technique is likely to rise at a steady rate. FFR is a procedure that helps in measuring the blood flow and pressure in the coronary artery. The measurement gives useful insights to cardiac surgeons on whether a surgery is required to remove the blockages.
According to the Centers for Disease Control and Prevention (CDC), heart-related diseases are the primary cause of death in people belonging to various racial or ethnic groups in the U.S. The report also states that every year nearly 805,000 U.S. citizens have suffered from at least one heart attack in their lifetime, which will boost the use of the FFR procedure.
There are many advantages associated with using the FFR technique to treat patients with cardiac ailments. First of all, the procedure helps surgeons determine the level of blockage in a patient’s artery by measuring the blood flow and pressure, which can eventually assist them in deciding whether surgery is compulsory. Since the FFR procedure uses a special guidewire to determine the level of blockage, it helps medical experts in choosing which patients really need the surgery. The freedom to take such decisions saves a lot of healthcare costs and plays a key role in enhancing the quality of patient care.
Secondly, various reliable studies have shown that patients who were screened out of angioplasty with the help of the FFR procedure did not face any adverse results. Moreover, the technique eliminated nearly one-third of the lesions, thereby bettering the quality of patient care. These benefits will positively influence the adoption of the FFR technique among healthcare experts.
Guidewires in the are expected to hold a major share of fractional flow reserve market over 2022-2028 as the instrument greatly helps cardiologists in determining the severity of a cardiovascular disease in a patient. Guidewires also help in the effortless placement of catheters that help patients better manage their condition.
The main role of guidewires in the FFR technique is to help surgeons determine the level of blockage in a patient’s arteries and aid them to make sound decisions with respect to surgery and patient care. Since the guidewires are minute in size, they can easily pass through the arteries, thereby increasing their use among surgeons.
The cases of single cell Coronary Artery Disease (CAD) in the fractional flow reserve market are anticipated to grow at a notable rate in many regions as there is a drastic change in the lifestyle and eating habits of the populations. More and more people are over-indulging in fast foods and pre-cooked foods due to their erratic schedules. There is a severe lack of physical exercise as they use vehicles to travel walkable distances.
These factors have increased the onset of chronic diseases, such as obesity, high blood pressure, and diabetes, thereby augmenting the risk of contracting cardiovascular disorders. Excessive consumption of junk foods and lack of physical activity lead to artery blockages, which will expand the adoption of the FFR technique to treat the medical conditions.
North America is set to witness a substantial rise in the use of the FFR procedure as the region’s geriatric population is growing at a steady rate every year. Moreover, according to the CDC, high blood cholesterol, smoking, and high blood pressure are the primary factors contributing to the increase in heart disorders.
The rapid growth in the number of fast food chains and the ever-expanding processed foods sector have made the consumers addicted to pre-cooked foods. The scenario will amplify the risk of contracting Coronary Artery Disease (CAD), which will foster the need for the FFR technique.
Some of the renowned companies are operating in the fractional flow reserve market are Abbott Laboratories, Opsens Medical, Boston Scientific Corporation, CathWorks, Koninklijke Philips N.V., Siemens Healthcare, Pie Medical Imaging, and ACIST Medical Systems, among many others. The organizations are entering into mergers, partnerships, and acquisitions with other firms to not only expand their global presence but also give them an opportunity to diversify their product and service range.
For example, Boston Scientific Corporation, in October 2021, announced its plans to acquire Baylis Medical Company Inc. for an upfront payment of $1.75 billion. The aim behind the acquisition is to introduce radiofrequency (RF) NRG and VersaCross Transseptal Platforms in the company, thereby expanding Boston Scientific’s structural heart and electrophysiology product portfolios. The deal will also help the company bring in a wide range of dilators, guidewires, and sheaths to enhance their healthcare efficiency.
The COVID-19 pandemic had a positive impact on the demand for the FFR technique among hospitals and other end-users as the virus was targeting people who were already suffering from weak immunity. Patients who were diagnosed with cardiovascular ailments were advised to continue with the FFR treatment to help them increase their survival rate and better manage their immunity level to stay protected from the virus.
Market, By Product
Market, By Type
The above information is provided for the following regions and countries: